IL6 and COVID-19: The strengths of our study include that it is the first time to detect decreased NEAT-1 in the serum of COVID-19 patients and the first study to measure serum miR374b-5p in COVID-19 patients and to correlate its level with NEAT-1, IL6, and other laboratory findings.